
|Articles|August 23, 2022
Daily Medication Pearl: Seizalam
Author(s)Saro Arakelians, PharmD
Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Advertisement
Medication Pearl of the Day: Midazolam injection (Seizalam)
Indication: Seizalam is a benzodiazepine indicated for the treatment of status epilepticus in adults.
Insight:
- Dosing: Injection: 50 mg/10 mL (5 mg/mL) in a multiple-dose vial.
- Dosage forms: The recommended dose is 10 mg, administered by intramuscular injection.
- Adverse events: The most common adverse reactions (incidence >3%) in clinical trials in patients with status epilepticus were upper airway obstruction, agitation, and pyrexia.
- Mechanism of action: The exact mechanism of action for midazolam in the treatment of status epilepticus is not fully understood but is thought to involve potentiation of GABAergic neurotransmission resulting from binding at the benzodiazepine site of the GABAA receptor.
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































